Results 291 to 300 of about 224,165 (338)

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In a six‐month randomized clinical trial, improved peripheral perfusion has been shown with liraglutide, associated with favourable vascular effects in people with type 2 diabetes and peripheral artery disease (PAD). We aimed to evaluate the durability of these benefits and to elucidate some mechanisms underlying liraglutide's effect over
Paola Caruso, Maria Ida Maiorino, Miriam Longo, Antonietta Maio, Lorenzo Scappaticcio, Nicole Di Martino, Carla Carbone, Mariluce Barrasso, Mariangela Caputo, Maurizio Gicchino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito   +12 more
wiley   +1 more source

SKIN REMOVAL IN RADICAL BREAST AMPUTATION

, 1943
John S. Rodman
openalex   +2 more sources

Pain modulation in amputees: Exploring conditioned pain modulation and its influencing factors on amputated and non-amputated sides: A cross-sectional study. [PDF]

Br J Pain
Barbosa Franco S, Di-Bonaventura S, Pacheco-Barrios K, Sugugawara A, Imamura M, Yoshioka LH, Battistella L, Fregni F.   +7 more
europepmc   +1 more source

Macrovascular and microvascular complications in US Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the incidence of macrovascular and microvascular complications in US Medicare enrollees diagnosed with T2D with and without established ASCVD. Materials and Methods We conducted a retrospective cohort study using Medicare fee‐for‐service claims data from 1 January 2006, through 31 December 2021. Baseline demographic and clinical
Tyler J. Dunn, Xi Tan, Joanna Harton, Sonia Kim, Lin Xie, Cory Gamble, Daniel Rotroff   +6 more
wiley   +1 more source

Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (RAPIDS‐UK) model

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare long‐term complications for people with type 2 diabetes mellitus (T2DM) following second‐line treatment in routine practice with sulphonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i), or sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) added to metformin.
Orlagh U. Carroll, Patrick Bidulka, Anirban Basu, Amanda I. Adler, Stephen O'Neill, Andrew H. Briggs, David G. Lugo‐Palacios, Kamlesh Khunti, Richard Grieve   +8 more
wiley   +1 more source

Facility-Level Variation in Major Leg Amputation Among Patients With Newly Diagnosed Diabetic Foot Ulcer.

JAMA Netw Open
Suzuki H, Vaughan-Sarrazin M, Ohl M, Mecham B, McCoy K, Brennan MB, Robbins JM, Livorsi DJ.   +7 more
europepmc   +1 more source

Comparison of Outcomes After Revascularization for Acute Lower Limb Ischemia in Patients with and without Type 2 Diabetes Mellitus - A Nationwide Registry Study. [PDF]

Vasc Health Risk Manag
Karonen E, Eek F, Drake I, Butt T, Carlsen HK, Eliasson B, Gottsäter A, Acosta S.   +7 more
europepmc   +1 more source

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) impose a vast health and economic burden on individuals and healthcare systems globally. We assessed the cost‐effectiveness of adding ON101, a novel treatment for accelerating wound healing, to general wound care (GWC) versus GWC alone for DFUs in Singapore, a multi‐ethnic country with increasing DFU prevalence
Hsuan‐Yu Su, Khong‐Yik Chew, Nicholas Graves, Huang‐Tz Ou   +3 more
wiley   +1 more source

Balance level of elite amputee football players. [PDF]

Sci Rep
Bednarczuk G, Marszałek J, Molik B, Nowak AM, Bastos T.   +4 more
europepmc   +1 more source